Cargando…
CD74 and intratumoral immune response in breast cancer
CD74 (invariant chain) plays a role in MHC class II antigen presentation. We assessed CD74 and MHCII expression in tumor cells, as well as CD8, CD4, and CD68 tumor infiltrating leucocyte (TIL) density by immunohistochemistry in a cohort of 492 breast cancer patients. CD74 expression was associated w...
Autores principales: | Wang, Zhi-Qiang, Milne, Katy, Webb, John R., Watson, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355043/ https://www.ncbi.nlm.nih.gov/pubmed/27058619 http://dx.doi.org/10.18632/oncotarget.8610 |
Ejemplares similares
-
PD-L1 and intratumoral immune response in breast cancer
por: Wang, Zhi-Qiang, et al.
Publicado: (2017) -
Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)
por: West, Nathan R., et al.
Publicado: (2011) -
Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
por: Webb, John R, et al.
Publicado: (2014) -
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017) -
Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells
por: Ssadh, Hussain Al, et al.
Publicado: (2017)